Search results
Results from the WOW.Com Content Network
Endovascular coiling is an endovascular treatment for intracranial aneurysms and bleeding throughout the body. The procedure reduces blood circulation to an aneurysm or blood vessel through the implantation of detachable platinum wires, with the clinician inserting one or more into the blood vessel or aneurysm until it is determined that blood flow is no longer occurring within the space.
An experimental new device currently undergoing clinical trials may soon offer a safer, faster treatment for aneurysms.
The EVD is leveled to a common reference point that corresponds to the skull base, usually the tragus or external auditory meatus.The EVD is set to drain into a closed, graduated burette at a height corresponding to a particular pressure level, as prescribed by a healthcare professional, usually a neurosurgeon or neurointensivist.
At a brain temperature of 14 °C, blood circulation can be safely stopped for 30 to 40 minutes. [3] There is an increased incidence of brain injury at times longer than 40 minutes, but sometimes circulatory arrest for up to 60 minutes is used if life-saving surgery requires it. [4] [5] Infants tolerate longer periods of DHCA than adults. [6]
Ohio woman underwent 12 procedures. Between Jan. 5 and Feb. 14, Smith underwent at least 12 procedures to treat the brain aneurysm, according to her husband.
The degree of aneurysm occlusion is graded on a five-point scale from 0 (no change in the endoaneurysmal flow) to 4 (complete obliteration of the aneurysm). The patency status of the parent artery is evaluated on a three-point scale, from no change in the parent artery diameter to parent artery occlusion. This grading system is used in clinical ...
For premium support please call: 800-290-4726 more ways to reach us
In March 2011, investigators from Australia and several other countries published the results of the DECRA [5] trial in The New England Journal of Medicine.This was a randomized trial comparing decompressive craniectomy to best medical therapy run between 2002 and 2010 to assess the optimal management of patients with medically refractory ICP following diffuse non-penetrating head injury.